Are antibiotic drugs well prescribed in case of renal insufficiency? A retrospective study

Renal Failure

Volumn 29, Issue 8, 2007, Pages 1055-1058

  Arlicot, Nicolas ^a   Pourrat, Xavier ^a   Bourgoin Hérard, Hélène ^a   Grassin, Jacqueline ^a   Antier, Daniel ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Antibiotics; Clinical pharmacy; Creatinine clearance; Renal insufficiency

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; CREATININE; OFLOXACIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PHARMACY; CLINICAL PROTOCOL; CREATININE CLEARANCE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE CALCULATION; DRUG MONITORING; FEMALE; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL WARD; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CREATININE; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 36849004574     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701643617     Document Type: Article

References (25)

1. Vernardet S, Bossaert S, Livrozet A, Pont E, Charpiat B. Pharmaceutical analysis and validation of hospital prescriptions: A five-year study. Presse Med. 2005;34(14): 990-996.
2. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
3. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39:S1-S246.
4. Baraldi A, Ballestri M, Rapana R, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant. 1998;13(Suppl. 7):S25-S29.
5. Dickerson LM, Mainous AG III, Carek PJ. The pharmacist's role in promoting optimal antimicrobial use. Pharmacotherapy. 2000;20:711-723.
6. Cunningham G, Dodd T, Grant DJ, McMurdo M, Richards M. Drug-related problems in elderly patients admitted to Tayside hospitals: Methods for prevention and subsequent reassessment. Age and Aging. 1997;26:375-382.
7. Chow KM, Szeto CC, Hui AC, Li PK. Mechanisms of antibiotic neurotoxicity in renal failure. Int J Antimicrob Agents. 2004;23(3):213-217.
8. Kenny GNC. Potential renal, hematological and allergic adverse effects associated with nonsteroidal anti-inflammatory drugs. Drugs. 1992;5:31-37.
9. ANAES Department of Professional Guidelines. Chronic renal failure diagnosis in adult. ANAES, St. Denis La Plaine, France; 2002.
10. st ed. Meditions International, Paris, 2002.
11. Nauta EH, Mattie H, Goslings WR. Pharmacokinetics of cloxacillin in patients on chronic intermittent hemodialysis and in healthy subjects. Chemotherapy. 1973;19(5):261-271.
12. Bulger RJ, Lindholm DD, Murray JS, Kirby WM. Effect of uremia on methicillin and oxacillin blood levels. Excretion and inactivation in renal failure and hemodialysis. JAMA. 1964;187(5):319-322.
13. Fillastre JP, Leroy A, Moulin B, Dhib M, Borsa-Lebas F, Humbert G. Pharmacokinetics of quinolones in renal insufficiency. Antimicrob Chemother. 1990;26(Suppl. B):51-60.
14. Patel IH, Sugihara JG, Weinfeld RE, Wong EG, Siemsen AW, Berman SJ. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Antimicrob Agents Chemother. 1984;25(4):438-442.
15. Turnidge J. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents. 1999;12(Suppl. 2): S23-S34.
16. Halstenson CE, Opsahl JA, Schwenk MH et al. Disposition of roxithromycin in patients with normal and severely impaired renal function. Antimicrob Agents Chemother. 1990;34(3):385-389.
17. Arancibia A, Drouguett MT, Fuentes G, et al. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function. Int J Clin Pharmacol Ther Toxicol. 1982;20(10):447-453.
18. Peddie B, Dann E, Bailey RR. The effect of impairment of renal function and dialysis on the serum level and urine levels of clindamycin. Aust N Z J Med. 1975;5(3):198-202.
19. Yeske H, Bradley JM. Dosage guidelines for cotrimoxazole in renal impairment. The Canadian Journal of Hospital Pharmacy. 1987;40(1):38-39.
20. Bassilios N, Vantelon C, Baumelou A, Deray G. Continuous rifampicin administration inducing acute renal failure. Nephrol Dial Transplant. 2001;16(1):190-191.
21. Borghetti A, Di Perna A, Novarini A, Bruschi G, Montanari A. Rifampicin kinetics in patients with kidney disease. Giornale di Clinica Medica. 1970;51(11):857-876.
22. Lam YW, Kapusnik-Uner JE, Sachdeva M, Hackbarth C, Gambertoglio JG, Sande MA. The pharmacokinetics of teicoplanin in varying degrees of renal function. Clin Pharmacol Ther. 1990;47:655-661.
23. Livornese LL Jr, Slavin D, Gilbert B, et al. Use of antibacterial agents in renal failure. Infect. Dis Clin North Am. 2004;18(3):551-579.
24. Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalized patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60(9):651-658.
25. Fredman B, Zohar E, Golan E, Tillinger M, Bernheim J, Jedeikin R. Diclofenac does not decrease renal blood flow or glomerular filtration in elderly patients undergoing orthopedic surgery. Anesth Analg. 1999;88:149-154.